Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · IEX Real-Time Price · USD
2.500
+0.030 (1.21%)
At close: Apr 18, 2024, 3:06 PM
2.450
-0.050 (-2.00%)
After-hours: Apr 18, 2024, 5:24 PM EDT

Minerva Neurosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013
Net Income
-30.01-32.11-49.911.94-72.18-50.17-31.52-31.05-27.08-56.9
Upgrade
Depreciation & Amortization
0.030.010.10.180.160.020.010.020.020.03
Upgrade
Share-Based Compensation
1.974.115.229.79.178.185.033.572.217.97
Upgrade
Other Operating Activities
13.223.3519.98-45.6419.420.0329.571.770.592.94
Upgrade
Operating Cash Flow
-14.78-24.65-24.6-33.82-43.43-41.943.09-25.69-24.27-35.96
Upgrade
Capital Expenditures
0-0.020000-0.0500-0.05
Upgrade
Acquisitions
0000000001.17
Upgrade
Change in Investments
00024.5314.0869.49-107.1417.82-18.280
Upgrade
Other Investing Activities
---------0.04-0.04
Upgrade
Investing Cash Flow
0-0.02024.5314.0869.49-107.1917.82-18.331.09
Upgrade
Share Issuance / Repurchase
200013.240.520.6652.1178.143151.88
Upgrade
Debt Issued / Paid
00000-4-4.94-1.57100
Upgrade
Other Financing Activities
-0.4-060------2.66-0.28
Upgrade
Financing Cash Flow
19.6-06013.240.52-3.3447.1776.5738.3451.6
Upgrade
Net Cash Flow
4.82-24.6635.43.94-28.8224.2-56.9368.7-4.2616.73
Upgrade
Free Cash Flow
-14.78-24.66-24.6-33.82-43.43-41.943.04-25.69-24.27-36.01
Upgrade
Free Cash Flow Margin
----82.14%------
Upgrade
Free Cash Flow Per Share
-2.27-4.62-4.61-6.63-8.91-8.650.64-6.52-8.29-22.64
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).